Dejar un mensaje
Si está interesado en nuestros productos y desea conocer más detalles, deje un mensaje aquí, le responderemos lo antes posible.
Brain Natriuretic Peptide (BNP) is applied for auxiliary diagnosis, risk stratification, and prognosis assessment of heart failure, as well as the differential diagnosis of cardiogenic and non-cardiogenic dyspnea.
BNP OEM kit utilizes a two-antibody sandwich immunoassay and is applicable to chemiluminescence platforms. Specific monoclonal antibodies target distinct epitopes on N-terminal and C-terminal regions of the BNP molecule to capture plasma BNP, delivering high sensitivity and exceptional specificity. Calibrated with high-purity recombinant BNP, the assay provides accurate, reliable, and stable quantitative results. Serving as a gold-standard biomarker for heart failure management, it supports early identification, clinical triage, and dynamic therapeutic monitoring of cardiac dysfunction.
★Bulk reagents are available with matching raw materials.
Marca :
QYM,SURFTECHArtículo n.° :
BNP-1Pedido (MOQ) :
On requestPago :
T/TOrigen del producto :
ChinaColor :
R1 should be a colorless to pale yellow transparent liquid; R2 should be a milky white suspension.Puerto de embarque :
Hefei or other portsPlazo de entrega :
On requestPeso :
On requestBNP OEM reagent
Product Specifications
| Product Name | BNP OEM reagent (chemiluminescence platforms) |
| Application: | It is applied for auxiliary diagnosis, risk stratification, and prognosis assessment of heart failure, as well as the differential diagnosis of cardiogenic and non-cardiogenic dyspnea. |
|
Assay Principle: |
Two-antibody sandwich immunoassay |
|
Sample Type: |
Serum / Plasma |
|
Calibrator Component: |
Recombinant BNP |
|
Sample volume |
50 μL |
|
Limit of detection |
15 pg/mL |
|
Measuring range |
15 pg/mL ~ 5000 pg/mL |
|
Reference interval |
100 pg/mL |
|
Traceability |
Abbott |
|
Precision |
Within-run ≤5%; Between-run ≤8% |
|
Interfering Substances |
Bilirubin ＜20 mg/dL; Triglycerides ＜3000 mg/dL; Biotin ≤30 ng/mL |
|
Method comparison |
Correlation coefficient (R²) ≥0.90 in large sample study vs Abbott assay |
|
Hook Effect Concentration |
100000 pg/mL |
| Package Size |
on request |
| Storage/Shipping | Store sealed and protected from light at 2 °C to 8 °C |
| Shelf Life | 12 months |
Product Advantages
1.Sensitivity complies with requirements
2.Good correlation across linear range
3.Outstanding precision at all concentrations
4.Stable long-term storage (heat resistance verified)
5.Strong correlation vs international mainstream brands in clinical comparison
Sensitivity Analysis Batch precision test Linear Range Validation
Clinical comparison Thermal damage test
Application Scenarios
Brain Natriuretic Peptide (BNP) is applied for auxiliary diagnosis, risk stratification, and prognosis assessment of heart failure, as well as the differential diagnosis of cardiogenic and non-cardiogenic dyspnea.
--------------占位---------------
FAQ
What is the reportable range and the upper limit for the high-dose Hook effect in acute heart failure?
The measuring range covers 15 pg/mL ~ 5000 pg/mL . The formulation prevents high-dose Hook effects up to 100000 pg/mL, eliminating false negatives in severe acute decompensated heart failure.
How well does it correlate with clinical reference platforms (e.g., Abbott )?
Excellent agreement. Clinical trials across heart failure cohorts yield R^2 > 0.95 against benchmark chemiluminescence BNP assays, ensuring identical clinical rule-out/rule-in cut-offs.
Dejar un mensaje
Escanear a WeChat :
Escanear a WhatsApp :
English
Español
IPv6 RED SOPORTADA